Login
$PRAX
$310.27 -$17.86 (5.44%) Live

$PRAX 8-K/A SEC Filings

Filed On Filing
10 Feb 2026 8-K/A: Departure/Election of Directors or Officers; Compensation

The purpose of this Non-Employee Director Compensation Policy (the “Policy”) of Praxis Precision Medicines, Inc. (the “Company”) is to provide a total compensation package that enables the Company to attract and retain, on a long-term ba...

11 Jul 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

On May 23, 2022, Praxis Precision Medicines, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) disclosing that the Board of Directors of the Company (the “Board”) elected Jill DeSimone to the Board as a Class I ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support